Literature DB >> 21272172

Use of risk stratification to guide ambulatory management of neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.

L J Worth1, S Lingaratnam, A Taylor, A M Hayward, S Morrissey, J Cooney, P A Bastick, R W Eek, A Wei, K A Thursky.   

Abstract

Utilization of risk-stratification tools in the setting of neutropenic fever is currently limited by inadequate knowledge and lack of awareness. Within this context, the approach to management of low-risk patients with neutropenic fever is inconsistent with the available evidence across many Australian treating centres. These clinical guidelines define and clarify an accepted standard of care for this patient group given the current evidence base. The Multinational Association for Supportive Care in Cancer risk index is presented as the preferred risk assessment tool for determining patient risk. Suitability of ambulatory care within specific patient populations is discussed, with defined eligibility criteria provided to guide clinical decision-making. Detailed recommendations for implementing appropriate ambulatory strategies, such as early discharge and outpatient antibiotic therapy, are also provided. Due consideration is given to infrastructural requirements and other supportive measures at a resourcing and operational level. An analysis of the relevant health economics is also presented.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272172     DOI: 10.1111/j.1445-5994.2010.02339.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  7 in total

1.  A new prognostic model for chemotherapy-induced febrile neutropenia.

Authors:  Shin Ahn; Yoon-Seon Lee; Jae-Lyun Lee; Kyung Soo Lim; Sung-Cheol Yoon
Journal:  Int J Clin Oncol       Date:  2015-06-07       Impact factor: 3.402

2.  Re: "problems with risk reclassification methods for evaluating prediction models".

Authors:  Nancy R Cook
Journal:  Am J Epidemiol       Date:  2011-08-24       Impact factor: 4.897

3.  Net reclassification improvement: a link between statistics and clinical practice.

Authors:  Maarten J G Leening; Nancy R Cook
Journal:  Eur J Epidemiol       Date:  2013-01-05       Impact factor: 8.082

4.  A proposal for a simplified MASCC score.

Authors:  Jasmijn C A Wierema; Matthew Links
Journal:  Support Care Cancer       Date:  2012-12-18       Impact factor: 3.603

5.  Clinically relevant measures of fit? A note of caution.

Authors:  Nancy R Cook
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

6.  Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center.

Authors:  Mike Nguyen; Tate Jacobson; Javier Torres; Alysson Wann
Journal:  Cancer Rep (Hoboken)       Date:  2021-02-26

7.  Usefulness of complete blood count parameters to predict poor outcomes in cancer patients with febrile neutropenia presenting to the emergency department.

Authors:  Arom Choi; Incheol Park; Hye Sun Lee; Jinseok Chung; Min Joung Kim; Yoo Seok Park
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.